Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001337264 | SCV001530860 | likely benign | Nemaline myopathy 2 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035826 | SCV004980577 | uncertain significance | Inborn genetic diseases | 2023-12-28 | criteria provided, single submitter | clinical testing | The c.3136A>G (p.N1046D) alteration is located in exon 31 (coding exon 29) of the NEB gene. This alteration results from a A to G substitution at nucleotide position 3136, causing the asparagine (N) at amino acid position 1046 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |